Fortrea Holdings Inc. FTRE

FTRE Company Overview

Fortrea Holdings Inc. is a global contract research organization (CRO) that provides clinical development solutions to the biopharmaceutical, biotechnology, and medical device industries. The company focuses on supporting drug and therapy development across the full clinical trial lifecycle, primarily serving mid-sized and large pharmaceutical companies as well as emerging biotechnology firms. Its services are designed to help clients accelerate development timelines, manage regulatory complexity, and generate clinical evidence required for product approval.

Fortrea was established in 2023 following the spin-off of Labcorp’s Clinical Development business, creating a standalone, publicly traded CRO with a singular focus on clinical research services. The company positions itself as a scientifically driven partner with deep therapeutic expertise, global scale, and an emphasis on operational rigor. Its strategic differentiation centers on therapeutic depth, especially in complex and late-stage clinical trials, and long-standing relationships with global biopharma sponsors.